pI: 4.615 |
Length (AA): 287 |
MW (Da): 33662 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129365)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G05440 | protein EMBRYO SAC DEVELOPMENT ARREST 35 |
Babesia bovis | BBOV_III007300 | hypothetical protein |
Candida albicans | CaO19.2721 | similar to CDC123 |
Candida albicans | CaO19.10236 | potential G1 to S transition factor |
Cryptosporidium hominis | Chro.60220 | hydrolase |
Cryptosporidium parvum | cgd6_1830 | HT-1080/Cdc123p - like protein |
Dictyostelium discoideum | DDB_G0276129 | cell division cycle protein 123 |
Echinococcus granulosus | EgrG_000735400 | cell division cycle protein 123 |
Entamoeba histolytica | EHI_128440 | cell division cycle protein 123 homolog, putative |
Echinococcus multilocularis | EmuJ_000735400 | cell division cycle protein 123 |
Giardia lamblia | GL50803_7593 | Hypothetical protein |
Homo sapiens | ENSG00000151465 | cell division cycle 123 |
Mus musculus | ENSMUSG00000039128 | cell division cycle 123 |
Saccharomyces cerevisiae | YLR215C | Cdc123p |
Schistosoma japonicum | Sjp_0011810 | Cell division cycle protein 123 homolog, putative |
Schistosoma japonicum | Sjp_0313400 | Cell division cycle protein 123 homolog, putative |
Schistosoma mansoni | Smp_167410 | hypothetical protein |
Schmidtea mediterranea | mk4.002090.03 | |
Theileria parva | TP04_0637 | hypothetical protein |
Trichomonas vaginalis | TVAG_384640 | cell division cycle protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
YLR215C | Saccharomyces cerevisiae | inviable | yeastgenome |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.